Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer

US Patent 10221244 · Granted Mar 5, 2019

Estimated economic value: $2,535,000

Assignee

Inventors

View full patent text on Google Patents →